CCL19 and neoplasm: For example, CCL21 and other lymphocyte specific chemokines such as EBI-1-ligand chemokine (ELC) and stromal cell-derived factor (SDF)-1alpha, showed anti-tumor immunity both systemically and locally in fibrosarcoma and ovarian tumor via activation of type 1 T cell response and IFN-γ generation [12].